WHO ICTRP trial

A trial of the clinical efficacy and safety of combined Chinese herbal medicine…

ChiCTR-IOR-16009378 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR-IOR-16009378
Public title A trial of the clinical efficacy and safety of combined Chinese herbal medicine granules with Promestriene for menopausal women with vulvovaginal atrophy
Scientific title A trial of the clinical efficacy and safety of combined Chinese herbal medicine granules with Promestriene for menopausal women with vulvovaginal atrophy
Primary sponsor Second Hospital Affiliated to Tianjin University of Traditional Chinese Medicine
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase Other
Countries China
Conditions Vulvovaginal atrophy
Interventions Experimental group:oral Chinese herbal medicine granules and topical Promestriene;The control group:Oral Chinese herbal medicine granules
Registration date Oct 11, 2016
Target size Experimental group:38;The control group:38
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations